Back to Results
First PageMeta Content
Health / Pharmaceutical industry / Research / Health Products and Food Branch / Pharmacology / Therapeutic Products Directorate / Good manufacturing practice / Regulatory affairs / Clinical trial / Health Canada / Medicine / Clinical research


Microsoft Word - copy for t[removed]eng.doc
Add to Reading List

Document Date: 2013-06-24 11:49:30


Open Document

File Size: 126,17 KB

Share Result on Facebook

City

Ottawa / /

Company

Merck Canada Inc. / GlaxoSmithKline Inc. / Hoffmann-La Roche Limited / Lundbeck Canada Inc. / Abbott Laboratories Limited / TPD Andrew Adams / Boehringer Ingelheim (Canada) Ltd. / Novartis Pharmaceuticals Canada Inc. / Janssen Inc. / AstraZeneca Canada Inc. / Pfizer Canada Inc. / Amgen Canada Inc. / /

Country

Canada / /

Event

FDA Phase / /

Facility

Western Ontario University of London / Ivey Centre / University of Western Ontario / Qualicum complex / /

IndustryTerm

manufacturing changes / drug product / electronic systems / food / health products / human pharmaceuticals / /

Organization

Bureau of Cardiology / Allergy and Neurological Sciences / Drug GMP Committee / Oncology Division / Health Products and Food Branch / Liaison Unit / Modern Regulatory Organization / Environmental Impact Initiative / Policy / Planning and International Affairs Directorate / Bureau of Policy / Science and International Programs / Scientific Advisory Committees Scientific Advisory Committee on Nonprescription Drugs Scientific Advisory / University of London / Medical Devices Bureau / Red Tape Commission / Regulatory Project Management Division / Bureau of Pharmaceutical Sciences / office of Regulatory Affairs / Committee on Pharmaceutical Sciences and Clinical Pharmacology Regulatory Proposals Arsenic Non-Medicinal Ingredients Formulations Regulatory Amendment Implementation of Non-Medicinal Ingredients Regulations / Biologics and Genetic Therapies Directorate / Regulatory Affairs Committee / Health Products Directorate / office of the Auditor General / Ivey Centre for Health Innovation and Leadership / Clinical Review Bureau / Regulatory Cooperation Commission / European Medicines Agency / office of Business Transformation / Therapeutic Products Directorate / Central Nervous System Division / University of Western Ontario in London / Director General’s Office / Managers and Regulatory Project Management Division / Bureau of Metabolism / Oncology and Reproductive Sciences / office of Clinical Trials / /

Person

Daniela Decina / Bruce Randall / Lynn Hefferton / Samar Darwish / Litowitz / Kimby Barton / Jennifer Chan / Caroline Vanneste / John Patrick Stewart / Linda Jack / Gay Parsons / Karen WallaceGraner / Staffing Kimby Barton / Tracey Spack / Carmen / Louise Déry / Karen Wallace-Graner / Megan Bettle / Ikaria / Supriya Sharma / Jared Rhines / Denise Quesnel / Angela Briginshaw / Andrew M. Adams / Gail Gervais / Barbara J. Sabourin / Matthew Ryan / Maria Perrotta / Loretta Del Bosco / Normand Laberge / Franca Mancino / Barbara Rotter / Andrew Adams / Carolyne Desrosiers / Elwyn Griffith / Lisa Lange / Georgette Roy / Barbara J Sabourin / Hieu Vu / Maria Klapka / /

Position

Prime Minister / Drug GMP Inspection Compliance Specialist / Director General / Acting Director / Vice-Chair / Manager / Acting Director General / consultant / Senior Executive Director / Director / Co-Chair / Chair / Forward Planning / /

Product

Supplemental New Drug Submission / New Drug / /

ProgrammingLanguage

php / /

ProvinceOrState

Ontario / North Carolina / /

PublishedMedium

the Canadian review / the NC review / the NC Foreign Review / the Use of Foreign Review / /

Region

Western Ontario / /

Technology

Quality of Service / GUI / Drug Development / /

URL

http /

SocialTag